These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21411554)

  • 1. Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood.
    Ohata Y; Arahori H; Namba N; Kitaoka T; Hirai H; Wada K; Nakayama M; Michigami T; Imura A; Nabeshima Y; Yamazaki Y; Ozono K
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E943-7. PubMed ID: 21411554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.
    Ohata Y; Yamazaki M; Kawai M; Tsugawa N; Tachikawa K; Koinuma T; Miyagawa K; Kimoto A; Nakayama M; Namba N; Yamamoto H; Okano T; Ozono K; Michigami T
    J Bone Miner Res; 2014 Jul; 29(7):1627-38. PubMed ID: 24470103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.
    Carpenter TO; Insogna KL; Zhang JH; Ellis B; Nieman S; Simpson C; Olear E; Gundberg CM
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E352-7. PubMed ID: 20685863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
    Takahashi H; Komaba H; Takahashi Y; Sawada K; Tatsumi R; Kanai G; Suzuki H; Kakuta T; Fukagawa M
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E652-8. PubMed ID: 24476081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates.
    Godang K; Frøslie KF; Henriksen T; Isaksen GA; Voldner N; Lekva T; Ueland T; Bollerslev J
    Eur J Endocrinol; 2013 Mar; 168(3):371-8. PubMed ID: 23221033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A; Liu Y; Pedersen L; Xia S; Roth HJ; Hocher B; Rasmussen LM; Tepel M
    J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects.
    Yamazaki Y; Imura A; Urakawa I; Shimada T; Murakami J; Aono Y; Hasegawa H; Yamashita T; Nakatani K; Saito Y; Okamoto N; Kurumatani N; Namba N; Kitaoka T; Ozono K; Sakai T; Hataya H; Ichikawa S; Imel EA; Econs MJ; Nabeshima Y
    Biochem Biophys Res Commun; 2010 Jul; 398(3):513-8. PubMed ID: 20599764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender Specific Association between Serum Fibroblast Growth Factor 23/α-Klotho and Coronary Artery and Aortic Valve Calcification.
    Morita H; Takeda Y; Fujita S; Okamoto Y; Sakane K; Teramoto K; Ozeki M; Tasaki R; Kizawa S; Sohmiya K; Hoshiga M; Ishizaka N
    J Atheroscler Thromb; 2015; 22(12):1338-46. PubMed ID: 26279337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum soluble α-Klotho levels in patients with autosomal dominant polycystic kidney disease.
    Sari F; Inci A; Dolu S; Ellidag HY; Cetinkaya R; Ersoy FF
    J Investig Med; 2017 Feb; 65(2):358-362. PubMed ID: 27733443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
    Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
    Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid Hormone and Plasma Phosphate Are Predictors of Soluble α-Klotho Levels in Adults of European Descent.
    Dhayat NA; Pruijm M; Ponte B; Ackermann D; Leichtle AB; Devuyst O; Ehret G; Guessous I; Pechère-Bertschi A; Pastor J; Martin PY; Burnier M; Fiedler GM; Vogt B; Moe OW; Bochud M; Fuster DG
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1135-43. PubMed ID: 31774122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
    Gkentzi D; Efthymiadou A; Kritikou D; Chrysis D
    Bone; 2014 Sep; 66():8-14. PubMed ID: 24880094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of klotho gene polymorphism and the regulation of calcium-phosphate metabolism disorders in patients with end-stage renal disease.
    Zeng QY; Xia ZY; Tong YS; Sun L; Mou HB; Chen R; Bi GY; Liu CH
    Nephrology (Carlton); 2019 Oct; 24(10):1001-1008. PubMed ID: 30537427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cinacalcet treatment on serum soluble Klotho levels in haemodialysis patients with secondary hyperparathyroidism.
    Komaba H; Koizumi M; Tanaka H; Takahashi H; Sawada K; Kakuta T; Fukagawa M
    Nephrol Dial Transplant; 2012 May; 27(5):1967-9. PubMed ID: 22140124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
    Kunert SK; Hartmann H; Haffner D; Leifheit-Nestler M
    J Bone Miner Metab; 2017 Mar; 35(2):215-226. PubMed ID: 27017221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays.
    Pedersen L; Pedersen SM; Brasen CL; Rasmussen LM
    Clin Biochem; 2013 Aug; 46(12):1079-1083. PubMed ID: 23707222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.